Designing future clinical trials in acute pancreatitis

Pancreatology

Volumn 5, Issue 2-3, 2005, Pages 113-115

  Mason, J ^a   Siriwardena, A K ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; LEXIPAFANT;

ACUTE PANCREATITIS; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; EDITORIAL; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MEDICAL RESEARCH; MORTALITY; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 19944414330     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000085261     Document Type: Editorial

References (18)

1. Eland IA, Sturkenboom JCM, Wilson JHP, Stricker BHC: Incidence and mortality of acute pancreatitis between 1985 and 1995. Scand J Gastroenterol 2000;35:1110-1116.
2. Powell JJ, Miles R, Siriwardena AK: Antibiotic prophylaxis in the initial management of severe acute pancreatitis. Br J Surg 1998;85:582-587.
3. Neoptolemos JP, Carr-Locke DL, London NJ, Bailey IA, James D, Fossard DP: Controlled trial of urgent endoscopie retrograde cholangiopancreatography and endoscopie sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet 1988; ii:979-983.
4. Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP, et al: Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001;48:62-69.
5. Abu-Zidan FM, Windsor JA: Lexipafant and acute pancreatitis: A critical appraisal of the clinical trials. Eur J Surg 2002;168:215-219.
6. Virlos IT, Mazzon E, Serraino I, Di Paola R, Genovese T, Britti D, Thiemermann C, Siriwardena A, Cuzzocrea S: Pyrrolidine dithiocarbamate reduces the severity of cerulein-induced murine acute pancreatitis. Shock 2003;20:544-550.
7. Hackert T, Werner J, Gebhard MM, Klar E: Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis. Surgery 2004;135:107-119.
8. Zeybek N, Gorgulu S, Yagci G, Serdar M, Simsek A, Kaymakcioglu N, Deveci S, Ozcelik H, Turfan T: The effects of gingko biloba extract (EGb 761) on experimental acute pancreatitis. J Surg Res 2003;115:286-293.
9. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW: Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-45.
10. Buter A, Imrie CW, Carter CR, Evans S, McKay CJ: Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 2002;89:675-681.
11. Larvin M, McMahon MJ: APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989;ii:201-205.
12. Lempinen M, Stenman UH, Puolakkainen P, Hietaranta A, Haapiainen R, Kemppainen E: Sequential changes in pancreatic markers in acute pancreatitis. Scand J Gastroenterol 2003;38:666-675.
13. Riche FC, Cholley BP, Laisne MJ, Vicaut E, Pannis YH, Lajeunie EJ, Boudiaf M, Valleur PD: Inflammatory cytokines, C reactive protein, and procalcitonin are early predictors of necrosis infection in acute necrotizing pancreatitis. Surgery 2003;133:257-262.
14. Werner J, Hartwig W, Uhl W, Muller C, Büchler MW: Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology 2003;3:115-127.
15. Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D: The logistic organ dysfunction system: A new way to assess organ dysfunction in the intensive care unit. ICU scoring group. JAMA 1996;276:802-810.
16. Glazer G, Mann DV: United Kingdom guidelines for the management of acute pancreatitis. Gut 1998;42:(suppl 2):S1-S13.
17. Kemppainen E, Sainio V, Haapiainen R, Kivisaari L, Kivilaakso E, Puolakkainen P: Early localization of necrosis by contrast-enhanced computed tomography can predict outcome in severe acute pancreatitis. Br J Surg 1996;83:924-929.
18. Powell JJ, Fearon KCH, Siriwardena AK: Current concepts of the pathophysiology and treatment of severe acute pancreatitis. Br J Int Care 2000;10:51-59.